Tag: SGLT2
-
Exploring the Longevity Potential of SGLT2 Inhibitors
From Diabetes Drugs to Life-Extending Agents The pursuit of longevity has entered an exciting new era with the unexpected emergence of sodium-glucose cotransporter 2 (SGLT2) inhibitors as potential lifespan-extending therapeutics. Originally developed to manage type 2 diabetes by promoting urinary glucose excretion, these drugs now show promise far beyond glycemic control. Mounting evidence from animal…